Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Stem cells versus donor specific transfusions for tolerance induction in living donor renal transplantation: a single-center experience.

Dave SD, Vanikar A, Trivedi HL, Gumber MR, Patel HV, Shah PR, Kute VB.

Transplantation. 2013 Jan 15;95(1):155-60. doi: 10.1097/TP.0b013e3182752bcc.

PMID:
23263505
[PubMed - indexed for MEDLINE]
2.

Stem cell transplantation in living donor renal transplantation for minimization of immunosuppression.

Vanikar AV, Trivedi HL.

Transplantation. 2012 Oct 27;94(8):845-50. doi: 10.1097/TP.0b013e3182664000.

PMID:
22992765
[PubMed - indexed for MEDLINE]
3.

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.

Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.

Transplant Proc. 2005 Mar;37(2):737-42.

PMID:
15848518
[PubMed - indexed for MEDLINE]
4.

Abrogation of antibodies improves outcome of renal transplantation.

Trivedi HL, Vanikar AV, Gumber MR, Patel HV, Shah PR, Kute VB.

Transplant Proc. 2012 Jan;44(1):241-7. doi: 10.1016/j.transproceed.2011.12.043.

PMID:
22310623
[PubMed - indexed for MEDLINE]
5.

The effect of stem cell transplantation on immunosuppression in living donor renal transplantation: a clinical trial.

Trivedi HL, Vanikar AV, Kute VB, Patel HV, Gumber MR, Shah PR, Dave SD, Trivedi VB.

Int J Organ Transplant Med. 2013;4(4):155-62.

PMID:
25013669
[PubMed]
Free PMC Article
6.

Renal transplantation in primary focal segmental glomerulosclerosis using a tolerance induction protocol.

Suthar K, Vanikar AV, Trivedi HL.

Transplant Proc. 2008 May;40(4):1108-10. doi: 10.1016/j.transproceed.2008.03.076.

PMID:
18555125
[PubMed - indexed for MEDLINE]
7.

Operational tolerance in living-related renal transplantation: a single-center experience.

Vanikar AV, Goplani KR, Feroz A, Kanodia KV, Patel RD, Suthar KS, Patel HV, Gumber MR, Shah PR, Trivedi HL.

Transplant Proc. 2011 Jun;43(5):1551-8. doi: 10.1016/j.transproceed.2011.01.161.

PMID:
21693233
[PubMed - indexed for MEDLINE]
8.

Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.

Donckier V, Troisi R, Toungouz M, Colle I, Van Vlierberghe H, Jacquy C, Martiat P, Stordeur P, Zhou L, Boon N, Lambermont M, Schandené L, Van Laethem JL, Noens L, Gelin M, de Hemptinne B, Goldman M.

Transpl Immunol. 2004 Sep-Oct;13(2):139-46.

PMID:
15380544
[PubMed - indexed for MEDLINE]
9.

Donor-specific transfusions have long-term beneficial effects for human renal allografts.

Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB.

Transplantation. 1995 Dec 27;60(12):1395-401.

PMID:
8545863
[PubMed - indexed for MEDLINE]
10.

Desensitization protocol for highly sensitized renal transplant patients: a single-center experience.

Kute VB, Vanikar AV, Trivedi HL, Shah PR, Goplani KR, Patel HV, Gumber MR, Patel RD, Kanodia KV, Suthar KS, Trivedi VB, Modi PR.

Saudi J Kidney Dis Transpl. 2011 Jul;22(4):662-9.

PMID:
21743208
[PubMed - indexed for MEDLINE]
Free Article
11.

Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.

Sharma RK, Rai PK, Kumar A, Kumar P, Gupta A, Kher V, Agrawal S, Bhandari M.

Nephron. 1997;75(1):20-4.

PMID:
9031265
[PubMed - indexed for MEDLINE]
12.

Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants.

Reed A, Pirsch J, Armbrust MJ, Burlingham WJ, Knechtle SJ, D'Alessandro AM, Sollinger HW, Lorentzen D, Kalayoglu M, Belzer FO.

Transplantation. 1991 Feb;51(2):382-4.

PMID:
1994532
[PubMed - indexed for MEDLINE]
13.

In pursuit of the ultimate: the initial Ahmedabad journey toward transplantation tolerance.

Trivedi HL, Vanikar AV, Modi PR, Shah PR, Shah VR, Trivedi VB.

Transplant Proc. 2007 Apr;39(3):653-7.

PMID:
17445566
[PubMed - indexed for MEDLINE]
14.

Stable graft function on low-dose steroid monotherapy in spite of donor-specific antibodies in renal transplantation combined with stem cell infusion.

Trivedi HL, Vanikar AV, Dave SD.

BMJ Case Rep. 2013 May 31;2013. pii: bcr2013009949. doi: 10.1136/bcr-2013-009949.

PMID:
23729716
[PubMed - indexed for MEDLINE]
15.

[Effect of donor-specific blood transfusion on the outcome of kidney transplantation].

Jovicić-Pavlović S, Lezaić V, Simić S, Blagojević-Lazić R, Stolić I, Simonović R, Radivojević-Djokić D, Djukanović L.

Srp Arh Celok Lek. 2003 Nov-Dec;131(11-12):449-53. Serbian.

PMID:
15114786
[PubMed - indexed for MEDLINE]
16.

A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.

Leone MR, Alexander SR, Melvin T, Striegel J, Reller K, Norman DJ, Barry JM.

J Urol. 1990 Sep;144(3):721-3.

PMID:
2388336
[PubMed - indexed for MEDLINE]
17.

Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.

Amada N, Okazaki H, Sato T, Ohashi Y, Kikuchi H.

Transplant Proc. 2005 Mar;37(2):927-9.

PMID:
15848577
[PubMed - indexed for MEDLINE]
18.

Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.

Marfo K, Akalin E, Wang C, Lu A.

Am J Health Syst Pharm. 2011 Dec 1;68(23):2276-82. doi: 10.2146/ajhp110120.

PMID:
22095818
[PubMed - indexed for MEDLINE]
19.

[ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona].

Oppenheimer F, Revuelta I, Serra N, Lozano M, Gutiérrez-Dalmau A, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Crespo M, Paredes D, Martorell J, Alcáraz A, Campistol JM.

Nefrologia. 2010;30(1):54-63. doi: 10.3265/Nefrologia.pre2009.Dic.5695. Epub 2009 Dec 14. Spanish.

PMID:
20038970
[PubMed - indexed for MEDLINE]
Free Article
20.

ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.

Nordén G, Briggs D, Cockwell P, Lipkin G, Mjörnstedt L, Mölne J, Ready A, Rydberg L, Samuelsson O, Svalander CT, Breimer ME.

Xenotransplantation. 2006 Mar;13(2):148-53.

PMID:
16623810
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk